Farmacia Hospitalaria y Farmacogenómica

Higuera, I; Garcia-Peris, P; Camblor, M; Breton, I; Velasco, C; Romero, R; Frias, L; Cuerda, C.

Outcomes of a general hospital-based Home Parenteral Nutrition (HPN) program; report of our experience from a 26-year period

NUTRICION HOSPITALARIA. 2014; 30(2): 359-365 Nº de citas: 24 [doi:10.3305/nh.2014.30.2.7592]

Solana, MJ; Colom, H; Lopez-Herce, J; Urbano, J; Gonzalez, R; Lopez, J; Manzanares, C; Carrillo, A.

Population Pharmacokinetics of Omeprazole in Critically Ill Pediatric Patients

THERAPEUTIC DRUG MONITORING. 2014; 36(4): 519-527 Nº de citas: 4

Marquinez-Alonso, I; Escudero-Vilaplana, V; Pernia, S; Bieler, CB; Fernandez-Llamazares, CM; Sanjurjo-Saez, M.

The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2014; 39(4): 376-382 Nº de citas: 4 [doi:10.1111/jcpt.12156]

de Lorenzo-Pinto, A; Bueno, H; Herranz-Alonso, A; Elizaga-Corrales, J; Perez-Sanz, C; Cuellar-Basterrechea, B; Fernandez-Aviles, F; Sanjurjo-Saez, M.

Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

International Journal of Clinical Pharmacy. 2014; 36(4): 821-826 Nº de citas: 2 [doi:10.1007/s11096-014-9972-3]

Cortejoso, L.; García, MI.; García Alfonso, P.; Grávalos, C.; Robles, L.; González Haba, E.; SANJURJO SAEZ, MARÍA; López Fernández, LA..

[Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2014; 38(4): 283-373

Valerio, M; Rodriguez-Gonzalez, CG; Munoz, P; Caliz, B; Sanjurjo, M; Bouza, E.

Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2014; 69(7): 1993-1999 Nº de citas: 115 [doi:10.1093/jac/dku053]

Ribed, A; Escudero-Vilaplana, V; Gonzalez-Haba, E; Sanjurjo, M.

Increased INR after gefitinib and acenocoumarol co-administration

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. 2014; 18(12): 1720-1722 Nº de citas: 2

Wheeler, HE; Gonzalez-Neira, A; Pita, G; de la Torre-Montero, JC; Alonso, R; Lopez-Fernandez, LA; Alba, E; Martin, M; Dolan, ME.

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses

PHARMACOGENETICS AND GENOMICS. 2014; 24(5): 231-237 Nº de citas: 14 [doi:10.1097/FPC.0000000000000037]

Romero, RM; Angulo, JM; Parente, A; Rivas, S; Tardaguila, AR.

Primary Obstructive Megaureter: The Role of High Pressure Balloon; Dilation

JOURNAL OF ENDOUROLOGY. 2014; 28(5): 517-523 Nº de citas: 31 [doi:10.1089/end.2013.0210]

Fernandez-Rozadilla, C; Cazier, JB; Tomlinson, I; Brea-Fernandez, A; Lamas, MJ; Baiget, M; Lopez-Fernandez, LA; Clofent, J; Bujanda, L; Gonzalez, D; de Castro, L; Hemminki, K; Bessa, X; Andreu, M; Jover, R; Xicola, R; Llor, X; Moreno, V; Castells, A; Castellvi-Bel, S; Carracedo, A; Ruiz-Ponte, C.

A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer

HUMAN GENETICS. 2014; 133(5): 525-534 Nº de citas: 19 [doi:10.1007/s00439-013-1390-4]

Duran, PA; Jimenez, RMR; Compes, CC; Alvarez, MC; Lesmes, IB; Pinto, AD; Bravo, SB; Soriano, LF; Peris, PG; Saez, MS.

HOME PARENTERALNUTRITION; SATISFACTION OF PATIENTS AND THEIR CAREGIVERS WITH NUTRITION UNIT AND PHARMACY SERVICE

NUTRICION HOSPITALARIA. 2014; 29(5): 1123-1131 Nº de citas: 2 [doi:10.3305/nh.2014.29.5.7371]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Iglesias-Peinado, I; Carrillo-Alvarez, A; Saez, MS; Fernandez-Llamazares, CM.

RISKS IN THE IMPLEMENTATION AND USE OF SMART PUMPS IN A PEDIATRIC INTENSIVE CARE UNIT: APPLICATION OF THE FAILURE MODE AND EFFECTS ANALYSIS

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2014; 30(2): 210-217 Nº de citas: 17 [doi:10.1017/S0266462314000051]

Perez-Granda, MJ; Barrio, JM; Munoz, P; Hortal, J; Rincon, C; Rabadan, PM; Pernia, MS; Bouza, E.

Ethanol Lock Therapy (E-Lock) in the Prevention of Catheter-Related Bloodstream Infections (CR-BSI) after Major Heart Surgery (MHS): A Randomized Clinical Trial

PLoS One. 2014; 9(3): Nº de citas: 25 [doi:10.1371/journal.pone.0091838]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Martinez-Martinez, F; Iglesias-Peinado, I; Carrillo-Alvarez, A; Sanjurjo-Saez, M; Fernandez-Llamazares, CM.

Implementing smart pump technology in a pediatric intensive care unit: A cost-effective approach

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2014; 83(2): 99-105 Nº de citas: 17 [doi:10.1016/j.ijmedinf.2013.10.011]

Manrique-Rodríguez S; Sánchez-Galindo A; Fernández-Llamazares CM; López-Herce J; Rodríguez-Gómez M; Echarri-Martínez L; Carrillo-Álvarez A; Sanjurjo-Sáez M.

Preparation of intravenous drug administration guidelines for a pediatric intensive care unit.

Journal Of Infusion Nursing : The Official Publication Of The Infusion Nurses Society. 2014; 37(1): 35-43 Nº de citas: 2 [doi:10.1097/NAN.0000000000000019]

Arrabal-Duran, P; Duran-Garcia, ME; Ribed-Sanchez, A; Hidalgo-Collazos, P; Sanjurjo-Saez, M.

Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure

NEFROLOGIA. 2014; 34(6): 710-715 Nº de citas: 8 [doi:10.3265/Nefrologia.pre2014.Jul.12541]

de Lorenzo-Pinto, A; Sanchez-Galindo, AC; Manrique-Rodriguez, S; Fernandez-Llamazares, CM; Fernandez-Lafever, SN; San-Prudencio, MG; Cortejoso, L; Sanjurjo-Saez, M.

Prevention and treatment of intraluminal catheter thrombosis in children hospitalised in a paediatric intensive care unit

JOURNAL OF PAEDIATRICS AND CHILD HEALTH. 2014; 50(1): 40-46 Nº de citas: 6 [doi:10.1111/jpc.12404]

Vega, A; Abad, S; Verdalles, U; Aragoncillo, I; Velazquez, K; Quiroga, B; Escudero, V; Lopez-Gomez, JM.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

Hippokratia. 2014; 18(4): 315-318 Nº de citas: 14